Calamos Advisors’s Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFNT.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-750,000
Closed -$30K 1021
2023
Q3
$30K Hold
750,000
﹤0.01% 801
2023
Q2
$99.8K Hold
750,000
﹤0.01% 801
2023
Q1
$135K Hold
750,000
﹤0.01% 892
2022
Q4
$49.5K Buy
+750,000
New +$75.2K ﹤0.01% 985

Calamos Advisors's NFNT.WS Position: Q4 2023 in Review

Calamos Advisors sold out of Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFNT.WS) in Q4 2023, closing a stake of 750,000 shares — an estimated $30K sold.

Calamos Advisors first reported a position in NFNT.WS in Q4 2022 and held it in 4 quarters. The position peaked at $135K in Q1 2023. 0 funds tracked by Wall St. Rank hold NFNT.WS as of Q4 2023.

  • Calamos Advisors reported no remaining Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2023 after selling out during the quarter.
  • Calamos Advisors sold 750,000 Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2023, an estimated $30K.
  • Calamos Advisors first reported a position in Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2022 and held it in 4 quarters.
  • Calamos Advisors's Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $135K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2023.

Based on Calamos Advisors's 13F filing for Q4 2023, filed 31 Jan 2024.